Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · IEX Real-Time Price · USD

2.450

-0.120 (-4.67%)

At close: Jul 19, 2024, 4:00 PM

2.470

+0.020 (0.82%)

Pre-market: Jul 22, 2024, 8:54 AM EDT

Vivos Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-15.64	-13.58	-23.85	-20.29	-17.99	-11.75	Upgrade
Depreciation & Amortization	0.59	0.62	0.67	0.73	0.72	0.75	Upgrade
Share-Based Compensation	1.09	1.11	2.4	2.68	2.17	1.99	Upgrade
Other Operating Activities	3.04	-0.09	1.19	1.14	3.49	2.68	Upgrade
Operating Cash Flow	-10.92	-11.95	-19.59	-15.74	-5.68	-5.34	Upgrade
Capital Expenditures	-0.72	-0.85	-0.92	-2.4	-0.12	-0.18	Upgrade
Acquisitions	0	0	0	-0.23	0	0.25	Upgrade
Change in Investments	0	0	0	0.01	0	0.01	Upgrade
Investing Cash Flow	-0.72	-0.85	-0.92	-2.61	-0.12	0.09	Upgrade
Share Issuance / Repurchase	4	12	0	27.93	22.29	1.25	Upgrade
Debt Issued / Paid	0	0	0	-0.03	1.19	3.73	Upgrade
Other Financing Activities	3.2	-1.08	-	-3.74	0.06	-0.51	Upgrade
Financing Cash Flow	7.2	10.92	0	24.17	23.54	4.47	Upgrade
Net Cash Flow	-4.44	-1.88	-20.51	5.82	17.74	-0.79	Upgrade
Free Cash Flow	-11.64	-12.8	-20.51	-18.13	-5.8	-5.52	Upgrade
Free Cash Flow Margin	-87.09%	-92.74%	-128.00%	-107.38%	-44.39%	-48.42%	Upgrade
Free Cash Flow Per Share	-5.04	-10.50	-22.28	-21.35	-11.27	-11.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).